Company · basf-6a780680
BASF
4 sourcescompanies-2026-11-14-0.1.0
Cite this record
ConductScience Library. BASF. Companies, record basf-6a780680. Release companies-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/companies/basf-6a780680
On this page
Company
The name as ClinicalTrials.gov gives it. A company is a name ClinicalTrials.gov classes as industry, and spellings that differ only in case or spacing are one; no subsidiary is folded into a parent. A trial of two phases counts in both, and recruiting trials count as active.
- Name
- BASF
- Trials
- 14
- As lead sponsor
- 0
- As collaborator
- 14
- Recruiting
- 0
- Active, recruiting or not
- 1
- Completed
- 10
- Stopped early, withdrawn or suspended
- 0
- Posted results
- 2
- Trials by phase
- Phase 2 1, Phase 3 1
- Drugs its trials test
- 6
- Comparisons calculated in its trials
- 2
- First trial registered
- 2005-09-20
- Last update
- 2026-10-16
Source ClinicalTrials.gov
Pipeline6
The drugs its trials test, by the trial links the pipelines release's checks show. The phase is the highest phase those trials registered on ClinicalTrials.gov, not a development stage. Highest phase first, then the most trials.
| Drug | Highest phase registered | Trials | As lead sponsor | Recruiting | Targets | Mechanism | In Drugs and targets | Source |
|---|---|---|---|---|---|---|---|---|
| CHOLECALCIFEROL | Phase 3 | 1 | 0 | 0 | VDR | Vitamin D receptor agonist | https://conductscience.org/library/drugs/CHEMBL1042 | Open Targets |
| OMEGA-3 FATTY ACIDS | Phase 3 | 1 | 0 | 0 | https://conductscience.org/library/drugs/CHEMBL4298065 | Open Targets | ||
| RETINOL | Phase 2 | 1 | 0 | 0 | https://conductscience.org/library/drugs/CHEMBL986 | Open Targets | ||
| BETA CAROTENE | Not applicable | 1 | 0 | 0 | https://conductscience.org/library/drugs/CHEMBL1293 | Open Targets | ||
| LUTEIN | Not applicable | 1 | 0 | 0 | https://conductscience.org/library/drugs/CHEMBL173929 | Open Targets | ||
| LYCOPENE | Not applicable | 1 | 0 | 0 | https://conductscience.org/library/drugs/CHEMBL501174 | Open Targets |
Trials14
The trials that name the company as lead sponsor or collaborator, newest registered first. Results posted are as ClinicalTrials.gov gave them on the day of the sponsors capture.
| Trial | Title | Role | Phase | Status | Type | Participants | Start | Results first posted | Drugs | In Trials | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06595472 | Plant Sterol-Enriched Palm Oil to Improve Lipid Profile and Inflammation in Hyperlipidemic Individuals | Collaborator | Not applicable | Completed | Interventional | 102 | 2012-06-01 | https://conductscience.org/library/trials/NCT06595472 | ClinicalTrials.gov | ||
| NCT05037890 | Effects of Plant Sterols and Stanols on Liver Inflammation | Collaborator | Not applicable | Unknown status | Interventional | 8 | 2020-02-20 | https://conductscience.org/library/trials/NCT05037890 | ClinicalTrials.gov | ||
| NCT04531137 | Conjugated Linoleic Acid on Body Weight and Body Fat Mass for 12 Weeks | Collaborator | Not applicable | Unknown status | Interventional | 84 | 2020-08-05 | https://conductscience.org/library/trials/NCT04531137 | ClinicalTrials.gov | ||
| NCT03725982 | Work Physiological-Biomechanical Analysis of a Passive Exoskeleton to Support Occupational Lifting and Flexing Processes | Collaborator | Not applicable | Completed | Interventional | 39 | 2019-01-18 | 2020-03-31 | https://conductscience.org/library/trials/NCT03725982 | ClinicalTrials.gov | |
| NCT03627819 | Plant Sterols and Plant Stanols and Liver Inflammation | Collaborator | Not applicable | Unknown status | Interventional | 15 | 2018-05-04 | https://conductscience.org/library/trials/NCT03627819 | ClinicalTrials.gov | ||
| NCT03592251 | 26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Memory Consolidation in Healthy Adults | Collaborator | Not applicable | Completed | Interventional | 168 | 2017-08-01 | https://conductscience.org/library/trials/NCT03592251 | ClinicalTrials.gov | ||
| NCT03559361 | 26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Sleep Efficiency in Healthy Adults | Collaborator | Not applicable | Completed | Interventional | 90 | 2017-03-01 | https://conductscience.org/library/trials/NCT03559361 | ClinicalTrials.gov | ||
| NCT03295032 | A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors | Collaborator | Not applicable | Completed | Interventional | 53 | 2016-03-01 | https://conductscience.org/library/trials/NCT03295032 | ClinicalTrials.gov | ||
| NCT03115775 | CLA and Vitamin D on Protein Turnover | Collaborator | Not applicable | Completed | Interventional | 40 | 2017-05-12 | https://conductscience.org/library/trials/NCT03115775 | ClinicalTrials.gov | ||
| NCT02137317 | Farming, Personal Protective Equipment, Nepal | Collaborator | Not applicable | Completed | Interventional | 45 | 2014-08 | https://conductscience.org/library/trials/NCT02137317 | ClinicalTrials.gov |
1 to 10 of 14
See all 14 trialsConditions18
The conditions its trials name, as the trials write them, with case and spacing folded. The most trials first.
| Condition | Trials |
|---|---|
| Acceptance and Commitment Therapy | 1 |
| Body Weight | 1 |
| Cancer | 1 |
| Cardiovascular Disease | 1 |
| Development and Health | 1 |
| HIV | 1 |
| Hyperlipidemias | 1 |
| Memory Consolidation | 1 |
| NASH - Nonalcoholic Steatohepatitis | 1 |
| Non-Alcoholic Fatty Liver Disease | 1 |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 conditionsPartners52
The other organizations its trials name, as lead sponsor or collaborator, with the class ClinicalTrials.gov gives each. The most trials shared first. A partner that is a company opens its own record.
| Organization | Class | Trials shared | In Companies | Source |
|---|---|---|---|---|
| Maastricht University Medical Center | Other | 2 | ClinicalTrials.gov | |
| Northumbria University | Other | 2 | ClinicalTrials.gov | |
| Raisio Group | Industry | 2 | https://conductscience.org/library/companies/raisio-group-142f31d2 | ClinicalTrials.gov |
| Unilever R&D | Industry | 2 | https://conductscience.org/library/companies/unilever-r-d-38516778 | ClinicalTrials.gov |
| University of Copenhagen | Other | 2 | ClinicalTrials.gov | |
| Aneurin Bevan University Health Board | Other | 1 | ClinicalTrials.gov | |
| Audi AG | Industry | 1 | https://conductscience.org/library/companies/audi-ag-d4d2515c | ClinicalTrials.gov |
| BMW AG | Industry | 1 | https://conductscience.org/library/companies/bmw-ag-7613845e | ClinicalTrials.gov |
| Bill and Melinda Gates Foundation | Other | 1 | ClinicalTrials.gov | |
| Bispebjerg Hospital | Other | 1 | ClinicalTrials.gov |
1 to 10 of 52
See all 52 partnersData dates
The date of each source this release read.
Sources 4
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL
- ClinicalTrials.govNo license stated
- Open TargetsCC0 1.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBLCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this company from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/companies/v1/basf-6a780680
GET https://conductscience.org/api/companies/v1/basf-6a780680/partners?page=2